Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines
| Author | Arezou Rabzia | en |
| Author | Mozafar Khazaei | en |
| Author | Zahra Rashidi | en |
| Author | Mohammad Rasoul Khazaei | en |
| Issued Date | 2017-10-31 | en |
| Abstract | Paclitaxel is one of the most common chemotherapeutic drugs used for the treatment of prostate cancer. However, its current clinical utility has been limited due to numerous serious side effects and drug resistance. Noscapine is an antitussive opium alkaloid that showed antitumor activity against a variety of cancer while it has not exhibited severe side effects. | en |
| DOI | https://doi.org/10.22037/ijpr.2017.2123 | en |
| Keyword | Apoptosis | en |
| Keyword | Chemotherapeutic drugs | en |
| Keyword | Noscapine | en |
| Keyword | Paclitaxel | en |
| Keyword | Prostate cancer | en |
| Publisher | Brieflands | en |
| Title | Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-16-1432.pdf
- Size:
- 636.53 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF